| Target ID: | dt241 |
|---|---|
| CID: | 4075 |
| Compound Name: | Mesalamine |
| Gene ID: | 5743 |
| Gene Name: | PTGS2 |
| Species: | Homo sapiens (human) |
| PubMed IDs: | -- |
| Action: | Inhibitor |
Knowledge Graph
| Target ID | CID | Compound Name | Gene ID | Gene Name | Species | Action | |
|---|---|---|---|---|---|---|---|
| dt1087 | 45138527 | Vb-201 | 5743 | PTGS2 | Homo sapiens (human) | -- | Details |
| dt112 | 2662 | Celecoxib | 5743 | PTGS2 | Homo sapiens (human) | Cyclooxygenase-2 inhibitor | Details |
| dt114 | 2662 | Celecoxib | 5743 | PTGS2 | Homo sapiens (human) | -- | Details |
| dt1330 | 5339 | Sulfasalazine | 5743 | PTGS2 | Homo sapiens (human) | -- | Details |
| dt1354 | 22419 | Olsalazine | 5743 | PTGS2 | Homo sapiens (human) | Inhibitor | Details |
| dt1366 | 5280933 | gamma-Linolenic acid | 5743 | PTGS2 | Homo sapiens (human) | Gamma-linolenic acid results in increased expression of PTGS2 mRNA | Details |
| dt216 | 3715 | Indomethacin | 5743 | PTGS2 | Homo sapiens (human) | -- | Details |
| dt355 | 5426 | Thalidomide | 5743 | PTGS2 | Homo sapiens (human) | -- | Details |
| dt522 | 54585 | Balsalazide | 5743 | PTGS2 | Homo sapiens (human) | Inhibitor | Details |
| dt526 | 54585 | Balsalazide | 5743 | PTGS2 | Homo sapiens (human) | -- | Details |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress | |
|---|---|---|---|---|---|---|---|
| Drug26 | Mesalazine | Chemical drug | -- | -- | -- | Under clinical trials | Details |
| Compound ID | Source ID | Source Type | Compound Name | Molecular Weight | Molecular Formula | Molecular Species | |
|---|---|---|---|---|---|---|---|
| No data available | |||||||
| Disease ID | Disease Name | Definition | Mechanism | |
|---|---|---|---|---|
| No data available | ||||
| Strategy ID | Therapy Strategy | Synonyms | Related Drugs | Mechanism | |
|---|---|---|---|---|---|
| No data available | |||||